Rituximab Product Approval Information - Licensing Action

Proper name: Rituximab
Tradename: Rituxan
Manufacturer: Genentech, Inc, South San Francisco, CA, License #1048
Indication for Use: Treatment of patients with relapsed or refractory low-grade or follicular, B-cell non-Hodgkin's lymphoma
Approval Date: 11/26/97
Type of submission: Biologics license application


Approval Letter - PDF

Label - PDF

Reviews (PDF)
    page number 20 posted 9/9/98]
    Product (9 pages)

Page Last Updated: 05/16/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English